ARWR
Price
$15.30
Change
-$0.99 (-6.08%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
2.25B
82 days until earnings call
IKT
Price
$1.96
Change
-$0.03 (-1.51%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
147.94M
Interact to see
Advertisement

ARWR vs IKT

Header iconARWR vs IKT Comparison
Open Charts ARWR vs IKTBanner chart's image
Arrowhead Pharmaceuticals
Price$15.30
Change-$0.99 (-6.08%)
Volume$61.31K
Capitalization2.25B
Inhibikase Therapeutics
Price$1.96
Change-$0.03 (-1.51%)
Volume$1.73K
Capitalization147.94M
ARWR vs IKT Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. IKT commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Buy and IKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (ARWR: $15.31 vs. IKT: $1.97)
Brand notoriety: ARWR: Notable vs. IKT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 100% vs. IKT: 69%
Market capitalization -- ARWR: $2.25B vs. IKT: $147.94M
ARWR [@Biotechnology] is valued at $2.25B. IKT’s [@Biotechnology] market capitalization is $147.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, ARWR is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 6 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 6 bullish, 4 bearish.
  • IKT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than IKT.

Price Growth

ARWR (@Biotechnology) experienced а +2.68% price change this week, while IKT (@Biotechnology) price change was -7.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

IKT is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.25B) has a higher market cap than IKT($148M). ARWR YTD gains are higher at: -18.564 vs. IKT (-39.385). IKT has higher annual earnings (EBITDA): -20.04M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. IKT (3.24M). IKT has less debt than ARWR: IKT (145K) vs ARWR (525M). ARWR has higher revenues than IKT: ARWR (2.5M) vs IKT (0).
ARWRIKTARWR / IKT
Capitalization2.25B148M1,520%
EBITDA-580.69M-20.04M2,898%
Gain YTD-18.564-39.38547%
P/E RatioN/AN/A-
Revenue2.5M0-
Total Cash553M3.24M17,047%
Total Debt525M145K362,069%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRIKT
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 7 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BABDX12.51N/A
N/A
BlackRock Global Dividend Inv A
LBDRX20.53N/A
N/A
BrandywineGLOBAL Div US Large Value R
VWNFX45.51N/A
N/A
Vanguard Windsor™ II Inv
JIGRX50.45-0.20
-0.39%
Janus Henderson Overseas S
MLVMX18.90-0.24
-1.25%
MFS Low Volatility Equity R1

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-6.02%
NTLA - ARWR
55%
Loosely correlated
-4.86%
DNLI - ARWR
54%
Loosely correlated
-4.20%
RGNX - ARWR
54%
Loosely correlated
-3.60%
BEAM - ARWR
52%
Loosely correlated
-2.99%
YMAB - ARWR
52%
Loosely correlated
-3.07%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-1.01%
CRGX - IKT
44%
Loosely correlated
-0.98%
ARWR - IKT
34%
Loosely correlated
-6.02%
IDYA - IKT
33%
Poorly correlated
-2.45%
KRYS - IKT
31%
Poorly correlated
-3.70%
KYMR - IKT
30%
Poorly correlated
-4.17%
More